Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 4Breast Neoplasms 3Recurrence 2Paraproteinemias 2Papillomavirus Infections 2Immunoglobulin Light-chain Amyloidosis 2Colorectal Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Thyroid Nodule 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Postoperative Complications 1Pneumonia 1Pancreatic Neoplasms 1Osteosarcoma 1Obesity 1Neoplasms, Plasma Cell 1Neoadjuvant Therapy in Rectal Cancer, Radiotherapy, FOLFOX 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, T-Cell 1Lymphoma, Mantle-Cell 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell 1Lung Neoplasms 1Lung Diseases, Interstitial 1Locally Advanced Breast Cancer 1Intermittent Fasting 1Hypothyroidism 1

Interventions

Blood Specimen Collection 8Magnetic Resonance Spectroscopy 5Pentoxifylline 4Liver Transplantation 4Tenofovir 3Specimen Handling 3High-Energy Shock Waves 3Tocopherols 2Sorafenib 2Simvastatin 2Low-Level Light Therapy 2Gemcitabine 2tremelimumab 1sonidegib 1sofosbuvir-velpatasvir drug combination 1ruxolitinib 1peginterferon alfa-2a 1navitoclax 1maltodextrin 1hepatitis B hyperimmune globulin 1esmolol 1epigallocatechin gallate 1durvalumab 1contrast agent BR1 1bavituximab 1atezolizumab 1apixaban 1alpha-Tocopherol 1adefovir dipivoxil 1Viusid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Clinical Protocols × Clear all
NCT05429190 2023-11-29

Validation of SMS Protocol for HCC Screening in High-risk Patients

Erasmus Medical Center

Enrolling by invitation
470 enrolled
Gastrointestinal

Fibrosis, Hepatitis, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡